Frequently Asked Questions
The market is segmented based on , By Product (Over-the-Counter (OTC) Rapid Test Product, Professional Rapid Test Product), Application (Infectious Disease, Cardiology, Oncology, Pregnancy and Fertility, Toxicology, Glucose Monitoring, Others), End User (Hospital and Clinic, Diagnostic Laboratory, Home Care, Others) – Industry Trends and Forecast to 2030.
.
The Global Preliminary Screening Tests Market size was valued at USD 2.80 USD Billion in 2022.
The Global Preliminary Screening Tests Market is projected to grow at a CAGR of 16% during the forecast period of 2023 to 2030.
The major players operating in the market include Akers Biosciences , Abbott, BD, Bio rad Laboratories , Cepheid, Hologic , Meridian Bioscience , OraSure Technologies , Quidel Corporation, F. Hoffmann La Roche Ltd, BUREAU VERITAS, Eurofins Scientific, Siemens Healthcare Private Limited, Luminex Corporation, PerkinElmer , QIAGEN, Mesa Biotech, Illumina .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
